Summit Trail Advisors’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
4,823
+610
+14% +$216K 0.02% 626
2026
Q1
$1.35M Buy
4,213
+138
+3% +$41.1K 0.02% 785
2025
Q4
$1.05M Sell
4,075
-4,276
-51% -$973K 0.02% 789
2025
Q3
$1.9M Buy
8,351
+7,150
+595% +$1.47M 0.03% 478
2025
Q2
$251K Buy
+1,201
New +$231K ﹤0.01% 983
2018
Q3
Sell
-369
Closed -$82K 387
2018
Q2
$82K Buy
+369
New +$68.2K 0.03% 241
2018
Q1
Sell
-444
Closed -$67K 1208
2017
Q4
$67K Buy
+444
New +$68.6K 0.01% 743

Other funds holding MSGS

Summit Trail Advisors's MSGS Position: Q2 2026 in Review

Summit Trail Advisors increased its Madison Square Garden (MSGS) stake by 14% in Q2 2026, buying an estimated $216K and bringing the position to 4,823 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #626.

Summit Trail Advisors first reported a position in MSGS in Q4 2017 and has held it in 7 quarters since. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Summit Trail Advisors held 4,823 shares of Madison Square Garden worth $1.94M as of Q2 2026.
  • Summit Trail Advisors bought 610 Madison Square Garden shares in Q2 2026, an estimated $216K.
  • Madison Square Garden made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #626 holding.
  • Summit Trail Advisors first reported a position in Madison Square Garden in Q4 2017 and has held it in 7 quarters since.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.